Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FYN binding protein 2 (FYB2) is a protein-coding gene product and adapter protein involved in T-cell receptor signaling and cell adhesion, especially in the immunological synapse and membrane raft domains of T cells. FYB2 plays a non-enzymatic role in amplifying or coordinating signals during T cell activation and mediates integrin-dependent adhesion. It is closely related to FYB1 (another adapter protein) and operates downstream of TCR ligation but is not currently considered a direct therapeutic target. Mutations or changes in FYB2 are associated with certain minor immune phenotypes, but its direct implications in major diseases or as a druggable target have not been established.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FYN binding protein 2 (FYB2).